Sagimet Biosciences Inc (Class A) Live Stock Price Today, Share Analysis and Chart

Name: Sagimet Biosciences Inc - Ordinary Shares - Class A: Is Infosys Ltd. worth buying?
Item: Sagimet Biosciences Inc - Ordinary Shares - Class A
Rating: 1.46783325
Author: Trendlyne DVM scores

about

Sagimet Biosciences Inc is a clinical-stage biopharmaceutical company dedicated to developing a portfolio of in-house discovered, selective fatty acid synthase (FASN) inhibitors aimed at treating diseases that arise from dysfunctional lipid metabolis...

6.35 -0.11 (-1.70%)

44.35% Fall from 52W High

809.3K

XNAS Volume

XNAS 04 Dec, 2025 4:30 PM (EST)

Not Eligible

Expensive Valuation

11.3 / 100

Technically Neutral

47.4 / 100

1Yr Price target upside is 380%

8 analysts

Sagimet Biosciences Inc (Class A) Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Sagimet Biosciences Inc (Class A) Live Stock Price Today, Share Analysis and Chart

Sagimet Biosciences Inc is a clinical-stage biopharmaceutical company dedicated to developing a portfolio of in-house discovered, selective fatty acid synthase (FASN) inhibitors aimed at treating diseases that arise from dysfunctional lipid metabolis...

44.35% Fall from 52W High

SWOT Analysis

Sagimet Biosciences Inc (Class A) Live Price Chart